Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Club cells in asthma: Multifunctional regulators of airway integrity and emerging therapeutic targets.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026

Same author

Respond to the commentary on "Government subsidy for infertility treatment: Impact on quality of life for infertile women undergoing in vitro fertilization-embryo transfer".

Journal of the Formosan Medical Association = Taiwan yi zhi·2026

Same author

Emerging role of SIRT1 in asthma and COPD from molecular mechanisms to translational therapy.

iScience·2026

Same author

Context matters: coordinated transcriptional regulation and root plasticity under multinutrient conditions.

The New phytologist·2026

Same author

Sex-specific alterations of niacin flush pathway biomarkers in schizophrenia.

Psychoneuroendocrinology·2026

Same author

ISX-TWIST1 reprograms CD47-inflammasome signaling to reshape the immune microenvironment in liver cancer.

Experimental hematology & oncology·2026

Search research articles

Related Experiment Video

Updated: Jan 11, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

Technologies for Monoclonal Antibody Discovery and Development.

Kyung Ho Han¹, Yi-Chuan Li^2,3, Rabia Parveen⁴

¹Department of Biological Sciences and Biotechnology, Hannam University, Daejeon 34054, Republic of Korea.

International Journal of Molecular Sciences

|November 13, 2025

Summary

Monoclonal antibody discovery utilizes diverse methods like hybridoma technology and phage display. Innovations in AI and antibody libraries accelerate the development of targeted biotherapeutics for various diseases.

Keywords:

antibody antibody engineering de novo synthesis hybridoma phage display

More Related Videos

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Laboratory Scale Production and Purification of a Therapeutic Antibody

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Related Experiment Videos

Last Updated: Jan 11, 2026

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

Laboratory Scale Production and Purification of a Therapeutic Antibody

Laboratory Scale Production and Purification of a Therapeutic Antibody

Published on: January 24, 2017

Area of Science:

Biopharmaceutical development
Therapeutic antibody engineering

Background:

Monoclonal antibodies (mAbs) are a successful biopharmaceutical class with over 100 approved therapies.
Diverse methodologies drive antibody discovery and development for oncological, immunological, and infectious diseases.

Purpose of the Study:

To review major approaches for antibody discovery and development.
To highlight innovative strategies accelerating therapeutic outcomes.

Main Methods:

Hybridoma technology
Phage display
Transgenic mouse models
Single B cell isolation
De novo antibody design
Artificial intelligence in antibody design

Main Results:

Classical and modern techniques generate high-affinity antibodies.
Functional antibodies can be selected for cellular environments, modulating signaling pathways.
AI and large databases are transforming computational protein design for antibodies.

Conclusions:

Multiple innovative strategies exist for antibody discovery and development.
These approaches aim to expedite the discovery process.
Enhanced therapeutic outcomes for human diseases are anticipated.